More than 400 people could benefit from life-extending advanced lung cancer treatment after it was recommended for routine use on the NHS

Durvalumab recommended as an option for treating non-small-cell lung cancer (NSCLC)

Read news story

  1. NICE outlines steps needed to put ME/CFS guideline into practice

    NICE has today, International ME Awareness Day (Thursday, 12 May 2022) published its implementation statement which sets out the practical steps needed to put its recent guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS) into


NICE Talks podcasts

NICE Talks brings you the real life experiences of people working within the NHS, public health and social care.

You will hear the stories behind our work to improve care across the country through evidence-based guidance.

Press and media

Contact the press office: 07973 970 534 |